Australia - englanti - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - glimepiride, quantity: 1 mg - tablet, uncoated - excipient ingredients: povidone; magnesium stearate; sodium starch glycollate type a; lactose monohydrate; iron oxide red - glimepiride astron is indicated as an adjunct to diet, exercise and weight loss to lower the blood glucose in patients with non-insulin-dependent diabetes mellitus (type 2)

Australia - englanti - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - glimepiride, quantity: 4 mg - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; sodium starch glycollate type a; povidone - glimepiride intas is indicated as an adjunct to diet, exercise and weight loss to lower the blood glucose in patients with non-insulin-dependent diabetes mellitus (type 2)

Australia - englanti - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - glimepiride, quantity: 3 mg - tablet, uncoated - excipient ingredients: magnesium stearate; povidone; lactose monohydrate; iron oxide yellow; sodium starch glycollate type a - glimepiride intas is indicated as an adjunct to diet, exercise and weight loss to lower the blood glucose in patients with non-insulin-dependent diabetes mellitus (type 2)

Australia - englanti - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - glimepiride, quantity: 2 mg - tablet, uncoated - excipient ingredients: povidone; lactose monohydrate; magnesium stearate; sodium starch glycollate type a; iron oxide red - glimepiride intas is indicated as an adjunct to diet, exercise and weight loss to lower the blood glucose in patients with non-insulin-dependent diabetes mellitus (type 2)

Australia - englanti - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - glimepiride, quantity: 1 mg - tablet, uncoated - excipient ingredients: povidone; magnesium stearate; sodium starch glycollate type a; lactose monohydrate; iron oxide red - glimepiride intas is indicated as an adjunct to diet, exercise and weight loss to lower the blood glucose in patients with non-insulin-dependent diabetes mellitus (type 2)

Yhdysvallat - englanti - NLM (National Library of Medicine)

medvantx, inc. - glimepiride (unii: 6ky687524k) (glimepiride - unii:6ky687524k) - glimepiride 2 mg - glimepiride tablets usp are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see clinical studies (14.1) ]. glimepiride tablets usp should not be used for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings. glimepiride tablets are contraindicated in patients with a history of a hypersensitivity reaction to: - glimepiride tablets or any of the product’s ingredients [see warnings and precautions (5.2) ]. sulfonamide derivatives: patients who have developed an allergic reaction to sulfonamide derivatives may develop an allergic reaction to glimepiride tablets. do not use glimepiride tablets in patients who have a history of an allergic reaction to sulfonamide derivatives. reported hypersensitivity reactions include cutaneous eruptions with or without pruritus as well as more serious reactions (e.g., anaphylaxis, angioedema, stevens-johnson syndrome, dyspnea) [see warnings and precauti

Yhdysvallat - englanti - NLM (National Library of Medicine)

st marys medical park pharmacy - glimepiride (unii: 6ky687524k) (glimepiride - unii:6ky687524k) - glimepiride 2 mg - glimepiride tablets usp are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [ see clinical studies ( 14.1) ] . glimepiride tablets usp should not be used for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings. glimepiride tablets are contraindicated in patients with a history of a hypersensitivity reaction to: - glimepiride tablets or any of the product’s ingredients [ see warnings and precautions ( 5.2) ]. sulfonamide derivatives: patients who have developed an allergic reaction to sulfonamide derivatives may develop an allergic reaction to glimepiride tablets. do not use glimepiride tablets in patients who have a history of an allergic reaction to sulfonamide derivatives. reported hypersensitivity reactions include cutaneous eruptions with or without pruritus as well as more serio

Yhdysvallat - englanti - NLM (National Library of Medicine)

ncs healthcare of ky, inc dba vangard labs - glimepiride (unii: 6ky687524k) (glimepiride - unii:6ky687524k) - glimepiride 1 mg - glimepiride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. [see clinical studies (14.1)].   glimepiride tablets should not be used for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings.  glimepiride tablets are contraindicated in patients with a history of a hypersensitivity reaction to : •    glimepiride or any of the product's ingredients [see warnings and precautions (5.2) ]. sulfonamide derivatives: patients who have developed an allergic reaction to aulfonamide derivatives may develop an allergic reaction to glimepiride. do not use glimepiride in patients who have a history of an allergic reaction to sulfonamide derivatives. reported hypersensitivity reactions include cutaneous eruptions with or without pruritus as well as more serious reactions (e.g., anaphylaxis, angioedema, stevens-johnson syndrome, dyspnea) [see warnings and precautions (5.2) and adverse r

Yhdysvallat - englanti - NLM (National Library of Medicine)

stat rx usa llc - glimepiride (unii: 6ky687524k) (glimepiride - unii:6ky687524k) - glimepiride 2 mg - glimepiride tablets, usp are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus (see dosage and administration section). glimepiride tablets, usp are contraindicated in patients with 1. known hypersensitivity to the drug. 2. diabetic ketoacidosis, with or without coma. this condition should be treated with insulin. the safety and efficacy of glimepiride were evaluated in an active-controlled, single-blind (patients only), 24-week trial involving 272 pediatric patients, ranging from 8 to 17 years of age, with type 2 diabetes. glimepiride (n=135) was administered at 1 mg initially, and then titrated up to 2, 4 or 8 mg (mean last dose 4 mg) until the therapeutic goal of self-monitored fasting blood glucose less than  7.0 mmol/l (less than 126 mg/dl) was achieved. the active comparator metformin (n=137) was administered at 500 mg twice daily initially and titrated up to 1000 mg twice daily (mean last dose 1365 mg). the profile of adverse rea

Yhdysvallat - englanti - NLM (National Library of Medicine)

rebel distributors corp - glimepiride (unii: 6ky687524k) (glimepiride - unii:6ky687524k) - glimepiride 2 mg - glimepiride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. (see dosage and administration section ).   glimepiride tablets are contraindicated in patients with 1. known hypersensitivity to the drug. 2. diabetic ketoacidosis, with or without coma. this condition should be treated with insulin.